Hepatitis E seroprevalence in East and West Flanders, Belgium

Acta Gastro-Enterologica Belgica

Volumn 75, Issue 3, 2012, Pages 322-324

  van Hoecke, F ^a   van Maerken, T ^a   de Boulle, M ^a   Geerts, A ^a   Vlierberghe, Van ^a   Colle, I ^a   Padalko, Elizaveta ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Belgium; Hepatitis E; HEV; IgG; Serology; Seroprevalence

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; BELGIUM; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOASSAY; MALE; SEROPREVALENCE; WESTERN EUROPE;

ADOLESCENT; ADULT; AGED; BELGIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84867294185     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. AGGARWAL R., NAIK S. Epidemiology of hepatitis E: current status. J. Gastroenterol. Hepatol., 2009, 24: 1484-1493.
2. DALTON H.R., BENDALL R., IJAZ S., BANKS M. Hepatitis E: an emerging infection in developed countries. Lancet Infect. Dis., 2008, 8: 698-709.
3. BENDALL R., ELLIS V., IJAZ S., ALI R., DALTON H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J. Med. Virol., 2010, 82: 799-805.
4. BOUTROUILLE A., BAKKALI-KASSIMI L., CRUCIÈRE C., PAVIO N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J. Clin. Microbiol., 2007, 45: 2009-2010.
5. MANSUY J.M., LEGRAND-ABRAVANEL F., CALOT J.P., PERON J.M., ALRIC L., AGUDO S. et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J. Med. Virol., 2008, 80: 289-293.
6. KNÖDLER B., HILLER J., LÖLIGER C.C., KÜHNL L. Hepatitis-EAntikörper bei Blutspendern, Hämodialysepatienten und in der Normal-bevölkerung. Beitr. Infusionsther. Transfusionsmed., 1994, 32: 124-127.
7. KRUMBHOLZ A., MOHN U., LANGE J., MOTZ M., WENZEL J.J., JILG W. et al. Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs. Med. Microbiol. Immunol., 2011. In press. Doi: 10.1007/s00430-011-0210-5.
8. PISCHKE S., HEIM A., BREMER B., RAUPACH R., HORNWICHMANN R., GANZENMUELLER T. et al. Hepatitis E: an emerging infectious disease in Germany? Z. Gastroenterol., 2011, 49: 1255-1257.
9. REIN D.B., STEVENS G., THEAKER J., WITTENBORN J.S., WIERSMA S.T. The global burden of hepatitis E virus. Hepatology, 2011 Nov 26. doi: 10.1002/hep.25505. [Epub ahead of print].
10. MAST E.E., ALTER M.J., HOLLAND P.V., PURCELL R.H. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology, 1998, 27: 857-861.
11. ZHANG J.Z., NG M.H., XIA N.S., LAU S.H., CHE X.Y., CHAU T.N. et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J. Med. Virol., 2001, 64: 125-132.
12. PERON J.M., MANSUY J.M., POIRSON H., BUREAU C., DUPUIS E., ALRIC L. et al. Hepatitis E is an autochthonous disease in industrialized countries: analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A. Gastroenterol. Clin. Biol., 2006, 30: 757-762.
13. DALTON H.R., STABLEFORTH W., THURAIRAJAH P., HAZELDINE S., REMNARACE R., USAMA W. et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur. J. Gastroenterol. Hepatol., 2008, 20: 784-790.
14. DE SILVA A.N., MUDDU A.K., IREDALE J.P., SHERON N., KHAKOO S.I., PELOSI E. Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: time for routine testing? J. Med. Virol., 2008, 80: 283-288.
15. BOUWKNEGT M., ENGEL B., HERREMANS M.M., WIDDOWSON M.A., WORM H.C., KOOPMANS M.P. et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands. Epidemiol. Infect., 2008, 136: 567-576.
16. HERREMANS M., VENNEMA H., BAKKER J., VAN DER VEER B., DUIZER E., BENNE C.A. et al. Swine-like hepatitis E viruses are a cause of unexplained hepatitis in the Netherlands. J. Viral Hepat., 2007, 14: 140-146.
17. WAAR K., HERREMANS M.M., VENNEMA H., KOOPMANS M.P., BENNE C.A. Hepatitis E is a cause of unexplained hepatitis in The Netherlands. J. Clin. Virol., 2005, 33: 145-149.
18. ZAAIJER H.L., KOK M., LELIE P.N., TIMMERMAN R.J., CHAU K., VAN DER PAL H.J.H. Hepatitis E in the Netherlands: imported and endemic. Lancet, 1993, 341: 826.
19. BERNAL W., SMITH H.M., WILLIAMS R. A community prevalence study of antibodies to hepatitis A and E in inner-city London. J. Med. Virol., 1996, 49: 230-234.
20. IJAZ S., VYSE A.J., MORGAN D., PEBODY R.G., TEDDER R.S., BROWN D. Indigenous hepatitis E virus infection in England: more common than it seems. J. Clin. Virol., 2009, 44: 272-276.
21. BUTI M., DOMÍNGUEZ A., PLANS P., JARDÍ R., SCHAPER M., ESPUÑES J. et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin. Vaccine Immunol., 2006, 13: 1328-1332.
22. LÓPEZ-IZQUIERDO R., UDAONDO M.A., ZARZOSA P., GARCÍARAMÓN E., GARCINUÑO S., BRATOS M.A., et al. Seroprevalencia de las hepatitis virales en población general representativa de una zona básica de salud urbana en Castilla y León. Enferm. Infecc. Microbiol. Clin., 2007, 25: 317-323.
23. MATEOS M.L., CAMARERO C., LASA E., TERUEL J.L., MIR N., BAQUERO F. Hepatitis E virus: relevance in blood donors and other risk groups. Vox Sang., 1998, 75: 267-269.